FDA’s draft rule ending menthol cigarettes proposes giving tobacco companies a year to clear menthol cigarettes off the market. FDA requested public comment on shortening the phase in 90 days. My UCSF and Stanford colleagues and I submitted this public comment (PDF version) supporting a 90 day phase in. We noted that FDA’s own analysisContinue reading “Cutting phase-in for cig menthol ban from 1 year to 90 days will prevent 265,000 kids from smoking and 12,000 premature deaths”
Author Archives: Stanton Glantz
FDA granting the tobacco companies’ request to extend the public comment period its menthol cigarette ban will lead to 58,000 more smokers and 2,700 more deaths
FDA has invited public comment on its well-justified rule to get rid of menthol cigarettes. Even though dealing with menthol cigarettes has been being considered and debated for 13 years, the tobacco companies have told FDA they need more time to prepare their comments and asked that the comment period be extended for 60 days.Continue reading “FDA granting the tobacco companies’ request to extend the public comment period its menthol cigarette ban will lead to 58,000 more smokers and 2,700 more deaths”
Direct evidence that Juul increases nicotine addiction, especially among kids
John Pierce and his colleagues at UCSD just published “Daily E-cigarette Use and the Surge in JUUL Sales: 2017-2019” that shows shows that after Juul came on the market there was a 3.6-fold higher rate of progression to daily e-cigarette use — a marker of addiction — among 14-17 year olds compared to 3 yearsContinue reading “Direct evidence that Juul increases nicotine addiction, especially among kids”
FDA prejudged e-cigs as good before it evaluated a single application
An August 31, 2020 memo detailing FDA’s plan for dealing with the expected flood of Premarket Tobacco Applications (PMTAs), clearly prejudges e-cigarettes as a good thing before looking at a single application. In particular, the FDA describes its “public heath goals” as including Ensure a variety of ENDS [electronic nicotine delivery systems] have an opportunityContinue reading “FDA prejudged e-cigs as good before it evaluated a single application”
FDA does JT/Logic’s work for it to justify authorizing 3 of its ENDS
On March 24, 2022 FDA authorized the sale of three electronic nicotine delivery systems distributed by Japan Tobacco’s US company Logic Technology Development, – two conventional e-cigarettes and one heated tobacco product. FDA withheld the Technical Project Lead (TPL) report that provides the scientific justifications for its decision. Thanks to my colleague Lauren Lempert filingContinue reading “FDA does JT/Logic’s work for it to justify authorizing 3 of its ENDS”
FDA proposed updating its HPHC list in 2019; it needs to finish the job
One of the nerdy, but very important, parts of the FDA tobacco product regulatory process is the list of “Hazardous and Potentially Hazardous Compounds” (HPHC) list that FDA released in 2012. This list contains 93 bad chemicals — mostly carcinogens — that FDA identified as important when assessing the risks of tobacco products. It hasContinue reading “FDA proposed updating its HPHC list in 2019; it needs to finish the job”
Texas Trump judge puts off effective date for FDA graphic cigarette warning labels again, this time until Jul 8, 2023
Last February, the Texas federal judge hearing the tobacco companies’ lawsuit against the graphic warning labels Congress ordered the FDA to put on cigarettes in 2009 delayed the implementation date until April 2023, after several such delays, first in May 2020. By the way, the judge didn’t actually rule against the FDA, he just putContinue reading “Texas Trump judge puts off effective date for FDA graphic cigarette warning labels again, this time until Jul 8, 2023”
FDA’s proposed ban on menthol cigarettes explains why FDA needs to reverse its de facto approvals of menthol e-cigarettes
The FDA’s decisions to act on premarket tobacco product applications (PMTAs) for e-cigarettes has been explicit about two points: (1) it is authorizing tobacco flavors because kids don’t seem to use tobacco flavored e-cigs and (2) it is blocking flavored e-cigs – except menthol – because kids like flavors. Because they can’t justify allowing mentholContinue reading “FDA’s proposed ban on menthol cigarettes explains why FDA needs to reverse its de facto approvals of menthol e-cigarettes”
FDA authorizes two more RJR tobacco e-cigs and lets menthol remain on the market, ignoring its own conclusion that menthol reinforces nicotine addiction in kids’ developing brains
Today (May 12, 2022) FDA announced that it was authorizing the sale of two additional RJR e-cigarettes, Vuse Vibe (a vape pen) and Vuse Ciro (similar to previously authorized Vuse Solo). FDA didn’t act on RJR’s most popular Vuse product, Vuse Alto, so it continues on the market. Following FDA’s de facto policy, both wereContinue reading “FDA authorizes two more RJR tobacco e-cigs and lets menthol remain on the market, ignoring its own conclusion that menthol reinforces nicotine addiction in kids’ developing brains”
1.4 million opioid industry documents now public for all the read at UCSF
Fourteen state attorneys general, in collaboration with UCSF and Johns Hopkins University just made 1.4 million previously secret opioid documents (8.1 million pages) publicly available at the UCSF Industry Documents Library. The AGs’ statement is worth quoting in full because it is important not only as a model for future opioid settlements and document disclosures,Continue reading “1.4 million opioid industry documents now public for all the read at UCSF”
Stanton Glantz blog 